Member Info for Aether

At the AGM, if the board are asked whether TGF have been made "insiders", are they required to answer?

Also, there are so many questions about new hires and their purpose for hire AND retention or even if some have been hired, specifically, the medical director role.

It looks like they were given the nod to be on a PT last year but it is either slow or may not happen so they have been forced to do something rather than wait.

They are being very VERY uncommunicative.

https://www.mayoclinic.org/diseases-conditions/narcissistic-personality-disorder/symptoms-causes/syc-20366662

Green bin.

Don't feed it.

From his posting history, the poster is obviously severely ill.

How much do you think this will rise if the small trials are successful?

*facepalm*

Another psycho. Into the green bin.

Good question. Why haven't the directors been spending their own money on buying shares?

There needs to be more information about the trials.

Hopefully, this will be forthcoming when the plans are completed.

I hope they make use of the diagnostic tests available and keep blood samples.

What is the time-span of the short trials?
Will they all be completed in H2?
How many are planned?

I suspect they were given the nod for a PT last year but, because COVID funding was reduced, it has been less easy to get on one.

If these mini-trials are good I will sell as they rise and buy back later as they wait for the next trial.

I need to reduce my exposure to this share.

The positives are we have more money than expected AND we have a semblance of a plan.

In the absence of any news, the sp will continue to drift.
There may be upticks at the announcement of the start of a small trial and a further uptick if a small trial is successful.
They certainly need to be successful now.

Also, funding specifically focused on host immune response needs to be released by the US gov as Rick Bright clearly stated.
If that happens, the likelihood of a PT increases significantly.

Tsk!

It's like buses - you wait for one and two come along at the same time!

Why are so many malignant lunatic posters attracted to Synairgen?

In this instance we know: It's because of Doc83!

XD

I am considering buying on a sudden dip in the sp and then wait for it to rise up to the AGM and sell the day before.

It is still possible that we will be considered for STRIVE though. I would welcome honest and comprehensive answers from RM at the AGM!

Our perception of our drug seems very different from the decision makers. However one of my tutors at pharmacy was very enthusiastic about the drug.

This is something important that needs discussing at the AGM.

They can't blunder again.

Fruits - I wasn't agitating for a change in the BoD. I was pointing out this would simply continue until they retire unless there is a PT or JV.

I am mildly pleased with the RNS because the cash burn is less than expected and there is *some* plan forward.

BUT it all hinges on a PT or JV now.

I just want to recoup some of the cash at this stage.

It will return to being a small university research aka AIM lifestyle company for RM and the clique until they step down UNLESS we get onto STRIVE or a JV.

On his salary, I'm not surprised.

100p is also my exit price. Given the sp recently doubled on no news and relatively low volume, I suspect it is an achieveable price. I am over-extended in this share. So, if Synairgen is included in another PT, I will not wait until completion again. This is still an AIM stock with no commercialised product.

This has been a brutal lesson.

SNG has survived for 20 years. It has good data and a need for it's product.
Whatever it did to survive in the past, it will do again (RM in a tiny room in SU with a dial-up connection but without a secretary).

But it will be a very long term hold then.

Personally, I am not expecting any news on Thursday and the speculative buys going in now will turn to sells causing a decline in the sp.

Then, the AGM where serious questions will need to be answered about what the new hires are doing, and whether the director of medical affairs was hired and for what purpose. Finally, questions about their salary because without any definite news, this is just an AIM company with zero commercialised products and suddenly it starts to look like an AIM lifestyle company with middle aged directors who are unlikely to get such well paying jobs again milking as much as they can from what remains of the capital our capital.

Then, we wait ...

... for news of UNIVERSAL and STRIVE.

If there is no new news on Thursday, I suspect the attitude towards the BoD will change significantly.

However, I doubt that the BoD are simply burning through money doing nothing because TFG would notice and start asking questions and making changes sharply.

Why though?

How does this compare to SNG?

If they don't pull something out of the hat, those high salaries will start to look difficult to justify.